Membrane Assays to Characterize Interaction of Drugs with ABCB1.

J Membr Biol 2015 Dec 30;248(6):967-77. Epub 2015 Apr 30.

Solvo Biotechnology, 2 Gyár St., Budaörs, 2040, Hungary.

ATP-binding cassette sub-family B member 1 (ABCB1) [P-glycoprotein (P-gp), multidrug resistance protein 1 (MDR1)] can affect the pharmacokinetics, safety, and efficacy of drugs making it important to identify compounds that interact with ABCB1. The ATPase assay and vesicular transport (VT) assay are membrane based assays that can be used to measure the interaction of compounds with ABCB1 at a lower cost and higher throughput compared to cellular-based assays and therefore can be used earlier in the drug development process. To that end, we tested compounds previously identified as ABCB1 substrates and inhibitors for interaction with ABCB1 using the ATPase and VT assays. All compounds tested interacted with ABCB1 in both the ATPase and VT assays. All compounds previously identified as ABCB1 substrates activated ABCB1-mediated ATPase activity in the ATPase assay. All compounds previously identified as ABCB1 inhibitors inhibited the ABCB1-mediated transport in the VT assay. Interestingly, six of the ten compounds previously identified as ABCB1 inhibitors activated the basal ATPase activity in activation assays suggesting that the compounds are substrates of ABCB1 but can inhibit ABCB1 in inhibition assays. Importantly, for ATPase activators the EC50 of activation correlated with the IC50 values from the VT assay showing that interactions of compounds with ABCB1 can be measured with similar levels of potency in either assay. For ATPase nonactivators the IC50 values from the ATPase inhibition and VT inhibition assay showed correlation. These results demonstrate the utility of membrane assays as tools to detect and rank order drug-transporter interactions.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00232-015-9804-yDOI Listing
December 2015
12 Reads

Publication Analysis

Top Keywords

compounds identified
16
identified abcb1
16
abcb1
13
abcb1 atpase
12
atpase
9
compounds
9
compounds abcb1
8
abcb1 inhibitors
8
ic50 values
8
atpase assay
8
transport assay
8
assays compounds
8
atpase activity
8
abcb1 substrates
8
atpase assays
8
membrane assays
8
assays
7
assay
7
activity activation
4
interestingly ten
4

References

(Supplied by CrossRef)

Y Adachi et al.
Pharm Res 2001

SV Ambudkar et al.
Proc Natl Acad Sci USA 1992

M Bauer et al.
Clin Pharmacol Ther 2012

M Bauer et al.
J Nucl Med 2013

M Bauer et al.
Neurology 2014

J Bentz et al.
Drug Metab Dispos 2013

S Bihorel et al.
Pharm Res 2007

HJ Broxterman et al.
Biochem Pharmacol 1988

N Buss et al.
Br J Clin Pharmacol 2001

S Callies et al.
Br J Clin Pharmacol 2003

RZ Cer et al.
Nucleic Acids Res 2009

Similar Publications